IDXX news

Latest 4 stories · newest Nov 2, 2026

IDXX

IDEXX Raises 2026 EPS Guidance Amid Q3 Revenue Beat

IDEXX Laboratories reported strong third quarter earnings and raised its 2026 financial outlook, citing double-digit growth in recurring diagnostics revenue and strong commercial execution.

Earnings|Guidance Nov 2, 2026 sentiment +0.70 SEC filing ↗

IDXX

Apple, Palantir On Deck Monday As AI Demand, iPhone Growth Face Test

Earnings Nov 1, 2026 sentiment 0.00 Source: benzinga.com ↗

IDXX

Insulet amends its exempt benefit plan

Insulet Corporation amended its NonQualified Deferred Compensation Plan effective January 1, 2027 to enhance management retention strategies and classify the program as a top-hat plan.

Leadership Sep 16, 2026 sentiment 0.00 SEC filing ↗

IDXX

IDXX Q2 EPS up 18% as revenue rises 10%

IDXX reported 10% revenue growth and 18% net income per share for Q2 2026. The company also raised its 2026 EPS outlook amidst innovation-driven growth segments like CAG Diagnostics.

Earnings|Guidance Aug 4, 2026 sentiment +0.90 SEC filing ↗

BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.

The same IDXX feed as JSON for your bot or app:

GET https://api.brieftape.com/v1/tickers/IDXX/newsSTART FREE